Vaccination

EU plans to scrap Valneva's COVID vaccine deal

The European Commission intends to terminate an agreement to buy the COVID vaccine of French-Austria drug maker Valneva as the shot has yet to receive marketing authorisation, the company said Monday.

Neuroscience

Sensing signals in paralyzed muscles

For people with tetraplegia—a condition in which all four limbs have lost motor ability—regaining independence is a top priority. Although there is no cure for paralysis caused by neurological disorders, robotic arms ...

Medications

New potential drugs for muscle dystrophy found using stem cells

Muscular dystrophy describes a group of genetic diseases in which muscles progressively weaken and degenerate, with Duchenne muscular dystrophy (DMD) being the most common. There are no curative treatments for DMD, and available ...

Vaccination

Swiss sign new Pfizer vaccine deal, eyeing booster shots

Switzerland announced Wednesday that it has signed a new contract with Pfizer for seven million COVID vaccine doses next year and in 2023, with an eye towards providing future booster shots.

page 5 from 22